CBL and hepatocellular carcinoma: The downregulation of CBL by miR-486-5p contributes to the suppression of HCC cell proliferation and migration, which underscores the potential therapeutic significance of targeting this miRNA-CBL axis in HCC treatment (He et al., 2019).